The future of Chagas disease control

被引:491
作者
Schofield, Chris J.
Jannin, Jean
Salvatella, Roberto
机构
[1] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[2] WHO, Neglected Trop Dis Dept, CH-1211 Geneva 27, Switzerland
[3] PAHO, Montevideo 11300, Uruguay
关键词
D O I
10.1016/j.pt.2006.09.011
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In the past 15 years, there have been major advances in the control of Chagas disease in most of the countries endemic for this infection. Attention now turns to the future continuity of surveillance and control interventions - especially in regions where control has been so successful that the epidemiological significance of Chagas disease is in steep decline. The effort and expenditure of the recent past cannot continue indefinitely, but a degree of surveillance and selective intervention will be required because of the risk of new infestations and infections resulting from adventitious silvatic vectors accidentally entering houses. In this review, we summarize the progress of multinational control initiatives against Chagas disease. In addition, we suggest that the most sustainable approach to future surveillance involves both the primary healthcare system and university-based teams, with progressively greater attention given to case detection and treatment. Such an idea is not new, but we believe that it merits extensive discussion because of the different ways that research and health interventions are financed and because of the need to establish clearer reporting links between the research communities and the national health authorities.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 51 条
  • [1] Biogeography of triatominae (Hemiptera: Reduviidae) in Ecuador:: Implications for the design of control strategies
    Abad-Franch, F
    Paucar, A
    Carpio, C
    Cuba, CAC
    Aguilar, HM
    Miles, MA
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2001, 96 (05): : 611 - 620
  • [2] Akhavan D., 2000, ANAL CUSTO EFETIVIDA
  • [3] [Anonymous], [No title captured]
  • [4] [Anonymous], 1993, World Development Report 1993: Investing in Healthl
  • [5] BAILEY GP, 2002, T R SOC TROP MED HYG, V96, P48
  • [6] BARBOS PRB, IN PRESS INT J CARDI
  • [7] Origin and phylogeography of the Chagas disease main vector Triatoma infestans based on nuclear rDNA sequences and genome size
    Bargues, MD
    Kiisiowicz, DR
    Panzera, F
    Noireau, F
    Marcilla, A
    Perez, R
    Rojas, MG
    O'Connor, JE
    Gonzalez-Candelas, F
    Galvao, C
    Jurberg, J
    Carcavallo, RU
    Dujarding, JP
    Mas-Coma, S
    [J]. INFECTION GENETICS AND EVOLUTION, 2006, 6 (01) : 46 - 62
  • [8] A cost-benefit analysis of Chagas disease control in north-western Argentina
    Basombrío, MA
    Schofield, CJ
    Rojas, CL
    del Rey, EC
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (02) : 137 - 143
  • [9] Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage
    Bustamante, JM
    Rivarola, HW
    Fernández, AR
    Enders, JE
    Fretes, R
    Palma, JA
    Paglini-Oliva, PA
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (07) : 889 - 896
  • [10] Cancado J.R., 1979, TRYPANOSOMA CRUZI DO, P362